Evidence map›Paper›PMID 30042377›Full record

ArticleMedical science monitor : international medical journal of experimental and clinical research2018

Upregulation of lncRNA-ATB by Transforming Growth Factor β1 (TGF-β1) Promotes Migration and Invasion of Papillary Thyroid Carcinoma Cells.

Meng Cui, Yu Chang, Wei Du, Shanting Liu, Jinxing Qi, Ruihua Luo, Suxia Luo

Open access · hybridAbstract read
In one paragraph

Article in Medical science monitor : international medical journal of experimental and clinical research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 31 citations in OpenAlex.

  1. Elucidation of Factors Affecting the Age-Dependent Cancer Occurrence Rates.International journal of molecular sciences · 2024
    Article
  2. Cells · 2022
    Article
  3. Article
  4. Mesenchymal stem cell-derived exosomes for gastrointestinal cancer.World journal of gastrointestinal oncology · 2021
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. LncRNA-ATB in cancers: what do we know so far?Molecular biology reports · 2020
    Review
  17. LncRNAs in HCV Infection and HCV-Related Liver Disease.International journal of molecular sciences · 2020
    Review
  18. Article
  19. Long Noncoding RNA and Epithelial Mesenchymal Transition in Cancer.International journal of molecular sciences · 2019
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Meng CuiDepartment of Head and Neck and Thyroid, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan, China (mainland).
Yu ChangDepartment of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China (mainland).
Wei DuDepartment of Head and Neck and Thyroid, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan, China (mainland).
Shanting LiuDepartment of Head and Neck and Thyroid, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan, China (mainland).
Jinxing QiDepartment of Head and Neck and Thyroid, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan, China (mainland).
Ruihua LuoDepartment of Head and Neck and Thyroid, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan, China (mainland).
Suxia LuoDepartment of Medical Oncology, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan, China (mainland).
Zhengzhou University · CNFirst Affiliated Hospital of Zhengzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND lncRNA-ATB plays an oncogenic role in various types of malignancies, but its involvement in papillary thyroid carcinoma (PTC) cells, which is a main type of thyroid cancer, is unknown. MATERIAL AND METHODS A total of 76 patients with PTC and 28 people with normal physiological conditions were included in this study. Tumor tissues and adjacent healthy tissues were collected from PTC patients and blood was extracted from both patients and healthy controls. Expression of lncRNA-ATB in those tissues was detected by qRT-PCR. All patients were followed up for 5 years and diagnostic and prognostic values of serum lncRNA-ATB for PTC were investigated by ROC curve analysis and survival curve analysis, respectively. lncRNA-ATB overexpression PTC cell lines were established and effects of lncRNA-ATB overexpression on cell migration and invasion were investigated by Transwell cell migration and invasion assay, respectively. Effects of lncRNA-ATB overexpression on TGF-β1 expression were investigated by Western blot. RESULTS lncRNA-ATB expression level was higher in tumor tissues than in adjacent healthy tissues in most PTC patients. Serum level of lncRNA-ATB was higher in cancer patients than in healthy control. Serum lncRNA-ATB can be used to accurately predict PTC and its prognosis. lncRNA-ATB overexpression promoted tumor cell migration and invasion, lncRNA-ATB overexpression showed no significant effects on TGF-β1 expression, and TGF-β1 treatment increased the expression level of lncRNA-ATB. CONCLUSIONS Upregulation of lncRNA-ATB by TGF-b1 promotes migration and invasion of PTC cells.

Indexed as

AdultAgedBiomarkers, TumorCarcinoma, PapillaryCase-Control StudiesCell Line, TumorCell MovementCell ProliferationFemaleHumansMaleMiddle AgedNeoplasm InvasivenessPrognosisRNA, Long NoncodingThyroid Cancer, PapillaryBiomarkers, Tumorlong non-coding RNA ATB, humanRNA, Long NoncodingTransforming Growth Factor beta1

Identifiers

PMID30042377
PMCPMC6071509
OpenAlexW2883289571

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.